Advertisement

Alopecia

  • Neusa Yuriko Sakai ValenteEmail author
  • Mai P. Hoang
Chapter
  • 89 Downloads

Abstract

In the hospitalized setting, hair loss, either telogen effluvium or anagen effluvium, is most commonly caused by drugs and anticancer therapy. Anticancer chemotherapy is a well-known cause of anagen effluvium. Other conditions associated with telogen effluvium include postpartum hormonal changes, medication, surgery, crash diet, hypothyroidism, and acute febrile illness. Pressure alopecia is a patchy, non-cicatricial, or cicatricial alopecia occurring on the scalp areas submitted to a prolonged pressure, either during surgery immobilization by coma. Diffuse hair loss can be the only manifestation of latent syphilis in the absence of other manifestations. Hair loss can present in various clinical patterns in patients with lupus erythematosus and half of those with systemic lupus erythematosus. These types of alopecia will be discussed in this chapter. Their histopathologic features are not specific; therefore, clinical pathologic correlation is essential.

Keywords

Alopecia Tinea capitis Pressure alopecia Anagen effluvium Telogen effluvium Drug-induced alopecia Chemotherapy-induced alopecia Antitumor necrosis factor Tyrosine kinase inhibitor Tacrolimus Nilotinib Lupus erythematosus Syphilitic alopecia 

References

  1. 1.
    Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol. 2009;19(3):R132–42.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Rezza A, Wang Z, Sennett R, Qiao W, Wang D, et al. Signaling networks between stem cell precursors, transit amplifying progenitors, and the niche in developing hair follicles. Cell Rep. 2016;14(12):3001–18.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Rahmani W, Abbasi S, Hagner A, Raharjo E, Kumar R, et al. Hair follicle dermal stem cells regenerate the dermal sheath, repopulate the dermal papilla, and modulate hair type. Dev Cell. 2014;31(5):543–58.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):1–3.Google Scholar
  5. 5.
    Geyfman M, Plikus MV, Treffeisen E, et al. Resting no more: re-defining telogen, the maintenance stage of the hair growth cycle. Biol Rev Camb Philos Soc. 2015;90(4):1179–96.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Headington JT. Transverse microscopic anatomy of the human scalp: a basis for a morphometric approach to disorders of the hair follicle. Arch Dermatol. 1984;120(4):449–56.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Thakur BK, Verma S, Raphael V. Clinical, trichoscopic, and histopathological features of primary cicatricial alopecias: a retrospective observational study at a tertiary centre of North East India. Int J Trichol. 2015;7(3):107–12.CrossRefGoogle Scholar
  8. 8.
    Moure ERD, Romiti R, Machado MCMR, Valente NYS. Primary cicatricial alopecias: a review of histopathologic findings in 38 patients from a clinical University Hospital in Sao Paulo. Brazil Clin. 2008;63(6):747–52.CrossRefGoogle Scholar
  9. 9.
    Harries MJ, Paus R. The pathogenesis of primary cicatricial alopecias. Am J Pathol. 2010;177(5):2152–62.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Rebora A. Proposing a simpler classification of telogen effluvium. Skin Appendage Disord. 2017;3(1):36–8.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    La Placa M, Balestri R, Bardazzi F, Vincenzi C. Scalp psoriasiform contact dermatitis with acute telogen effluvium due to topical minoxidil treatment. Skin Appendage Disord. 2015;1(3):141–3.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Loh SH, Lew BL, Sim WY. Localized telogen effluvium following hair transplantation. Ann Dermatol. 2018;30(2):214–7.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Shin S, Kim DY. Suprabulbar thinning of hair in telogen effluvium. Yonsei Med J. 2017;58(3):682.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Dhurat R, Saraogi P. Hair evaluation methods: merits and demerits. Int J Trichol. 2009;1(2):108–19.CrossRefGoogle Scholar
  15. 15.
    Fonia A, Cota C, Setterfield JF, Goldberg LJ, Fenton DA, Stefanato CM. Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: clinicopathologic findings in a cohort of 10 patients. J Am Acad Dermatol. 2017;76(5):948–57.PubMedCrossRefGoogle Scholar
  16. 16.
    Combalia A, Baliu-Piqué C, Fortea A, Ferrando J. Anagen effluvium following acute colchicine poisoning. Int J Trichol. 2016;8(4):171–2.CrossRefGoogle Scholar
  17. 17.
    Dhurat RP, Deshpande DJ. Loose anagen hair syndrome. Int J Trichol. 2010;2(2):96–100.CrossRefGoogle Scholar
  18. 18.
    Hadayer N, Ramot Y, Maly A, Zlotogorski A. Pemphigus vulgaris with loss of hair on the sdcalp. Int J Trichol. 2013;5(3):157–8.CrossRefGoogle Scholar
  19. 19.
    Lee HJ, Ha SJ, Lee JH, Kim JW, Kim HO, Whiting DA. Hair counts from scalp biopsy specimens in Asians. J Am Acad Dermatol. 2002;46(2):218–21.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Doche I, Hordinsky MK, Valente NYS, Romiti R, Tosti A. Syphilitic alopecia: case reports and trichoscopic findings. Skin Appendage Disord. 2017;3(4):222–4.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Leitão JR, Valente NYS, Kakizaki P, Veronez IS, Pires MC. Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib. An Bras Dermatol. 2016;91(5 suppl 1):45–7.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Belum VR, Marulanda K, Ensslin C, et al. Alopecia in patients treated with molecularly targeted anticancer therapies. Ann Oncol. 2015;26(12):2496–502.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Tawil MH, El Khoury R, Tomb R, Ghosn M. Nilotinib-induced keratosis pilaris associated with alopecia areata and eyebrow thinning. Int J Trichol. 2017;9(2):87–9.Google Scholar
  24. 24.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol. 2009;61(3):486–504.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Agero AL, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. 2006;55(4):657–70.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Carlos G, Anforth R, Clements A, et al. Cutaneous toxic effects of BRAF inhibitors alone and in combination with MEK inhibitors for metastatic melanoma. JAMA Dermatol. 2015;151(10):1103–9.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Dika E, Patrizi A, Ribero S, et al. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma. Eur J Dermatol. 2016;26(3):232–9.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Alkeraye S, Maire C, Desmedt E, Templier C, Mortier L. Persistent alopecia induced by vismodegib. Br J Dermatol. 2015;172(6):1671–2.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Trueb RM. Chemotherapy-induced alopecia. Semin Cutan Med Surg. 2009;28(1):11–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Gerrard GE, Prestwich RJ, Edwards A, Russon LJ, Richards F, et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol. 2003;15(7):422–8.CrossRefGoogle Scholar
  32. 32.
    Yun SJ, Kim SJ. Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation. Dermatology. 2007;215(1):36–40.PubMedCrossRefGoogle Scholar
  33. 33.
    Tsalic M, Gilboa M, Visel B, Miller B, Haim N. Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity. Med Oncol. 2006;23(1):57–61.PubMedCrossRefGoogle Scholar
  34. 34.
    Hansen T, Little AJ, Miller JJ, Ioffreda MD. A case of inflammatory nonscarring alopecia associated with the tyrosine kinase inhibitor nilotinib. JAMA Dermatol. 2013;149(3):330–2.PubMedCrossRefGoogle Scholar
  35. 35.
    Osório F, Magro F, Lisboa C, et al. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature. Dermatology. 2012;225(2):163–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Gallicchio L, Calhoun C, Helzlsouer KJ. Aromatase inhibitor therapy and hair loss among breast cancer survivors. Breast Cancer Res Treat. 2013;142(2):435–43.PubMedCrossRefGoogle Scholar
  37. 37.
    Baker BW, Wilson CL, Davis AL, Spearing RL, Hart DN, et al. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transplant. 1991;7(1):43–7.PubMedGoogle Scholar
  38. 38.
    Wen CS, Lin SM, Chen Y, Chen JC, Wang YH, Tseng SH. Radiation-induced temporary alopecia after embolization of cerebral arteriovenous malformations. Clin Neurol Neurosurg. 2003;105(3):215–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Tricot L, Lebbé C, Pillebout E, et al. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation. 2005;80(11):1546–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Zuk DM, Koh A, Imes S, Shapiro AMJ, Senior PA. Three cases of alopecia following clinical islet transplantation. Am J Transplant. 2011;11(1):163–8.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Kinahan KE, Sharp LK, Seidel K, Leisenring W, Didwania A, et al. Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2012;30(20):2466–74.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Kang D, Kim IR, Choi EK, Im YH, Park YH, et al. Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study. Oncologist. 2019;24(3):414–20.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Craddock LN, Cooley D, Endo JO, et al. TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold. Dermatol Online J. 2017;23(3):1–19.Google Scholar
  44. 44.
    Udkoff J, Cohen PR. Severe infliximab-induced alopecia and scalp psoriasis in a woman with Crohn’s disease: dramatic improvement after drug discontinuation and treatment with adjuvant systemic and topical therapies. Dermatol Ther. 2016;6(4):689–95.CrossRefGoogle Scholar
  45. 45.
    Chang ZY, Ngian J, Chong C, Chong CT, Liew CY. Postoperative permanent pressure alopecia. J Anesth. 2016;30(2):349–51.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Papaiordanou F, Silveira BRL, Piñeiro-Maceira J, Pirmez R. Trichoscopy of noncicatricial pressure-induced alopecia resembling alopecia areata. Int J Trichol. 2016;8(2):89–90.CrossRefGoogle Scholar
  47. 47.
    Khokhar RS, Baaj J, Alhazmi HH, Dammas FA, Aldalati AM. Pressure-induced alopecia in pediatric patients following prolonged urological surgeries: the case reports and a review of literature. Anesth Essays Res. 2015;9(3):430–2.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Goodenough J, Highgate J, Shaaban H. Under pressure? Alopecia related to surgical duration. Br J Anaesth. 2014;113(2):306–7.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Udompanich S, Chanprapaph K, Suchonwanit P. Hair and scalp changes in cutaneous and systemic lupus erythematosus. Am J Clin Dermatol. 2018;19(5):679–94.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Yun SJ, Lee JW, Yoon HJ, Lee SS, Kim SY, et al. Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia. J Dermatol. 2007;34(7):451–5.PubMedCrossRefGoogle Scholar
  51. 51.
    Concha JSS, Werth VP. Alopecias in lupus erythematosus. Lupus Sci Med. 2018;5:e000291.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Amas-Cruz R, Harnecker J, Ducach G, Jalil J, Gonzalez F. Clinical diagnosis of systemic lupus erythematosus. Am J Med. 1958;25(3):409–19.CrossRefGoogle Scholar
  53. 53.
    Chung HJ, Goldberg LJ. Histologic features of chronic cutaneous lupus erythematosus of the scalp using horizontal sectioning: emphasis on follicular findings. J Am Acad Dermatol. 2017;77(2):349–55.PubMedCrossRefGoogle Scholar
  54. 54.
    Ye Y, Zhao Y, Gong Y, Zhang X, Caulloo S, et al. Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata. Lupus. 2013;22(14):1439–45.PubMedCrossRefGoogle Scholar
  55. 55.
    Cuozzo DW, Benson PM, Sperling LC, Skelton HG. Essential syphilitic alopecia revisited. J Am Acad Dermatol. 1995;32(5 Pt 2):840–4.PubMedCrossRefGoogle Scholar
  56. 56.
    Jordaan HF, Louw M. The moth-eaten alopecia of secondary syphilis. Am J Dermatopathol. 1995;17(2):158–62.PubMedCrossRefGoogle Scholar
  57. 57.
    Hernandez-Bel P, Unamono B, Sanchez-Carazo JL, Febrer I, Alegre V. Syphilitic alopecia: a report of 5 cases and a review of the literature. Actas Dermosifiliogr. 2013;104(6):512–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Nam-Cha SH, Guhl G, Fernandez-Pena P, Fraga J. Alopecia syphilitica with detection of Treponema pallidum in the hair follicle. J Cutan Pathol. 2007;34(suppl 1):37–40.PubMedCrossRefGoogle Scholar
  59. 59.
    Piraccini BM, Broccoli A, Starace M, Gaspari V, D’Antuono A, et al. Hair and scalp manifestations in secondary syphilis: epidemiology, clinical features and trichoscopy. Dermatology. 2015;231(2):171–6.PubMedCrossRefGoogle Scholar
  60. 60.
    Ye Y, Zhang X, Zhao Y, Gong Y, Yang J, et al. The clinical and trichoscopic features of syphilitic alopecia. J Dermatol Case Rep. 2014;8(3):78–80.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Lee JY, Hsu ML. Alopecia syphilitica, a simulator of alopecia areata: histopathology and differential diagnosis. J Cutan Pathol. 1991;18(2):87–92.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Tognetti L, Cinotti E, Perrot JL, Campoli M, Rubegni P. Syphilitic alopecia: uncommon trichoscopic findings. Dermatol Pract Concept. 2017;7(3):55–9.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Inui S, Nakajima T, Nakagawa K, Itami S. Clinical significance of dermoscopy in alopecia areata: analysis of 300 cases. Int J Dermatol. 2008;47(7):688–93.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Kallel A, Hdider A, Fakhfakh N, Belhadj S, Belhadj-Salah N, Bada N, et al. Tinea capitis: main mycosis child: epidemiological study on 10 years. J Mycol Med. 2017;27(3):345–35.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Jo JH, Deming C, Kennedy EA, et al. Diverse human skin fungal communities in children converge in adulthood. J Invest Dermatol. 2016;136(12):2356–63.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Veasey JV, GSC M. Tinea capitis: correlation of clinical presentations to agents identified in mycological culture. An Bras Dermatol. 2018;93(3):465–6.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    John AM, Schwartz RA, Janniger CK. The kerion: an angry tinea capitis. Int J Dermatol. 2018;57(1):3–9.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Furlan KC, Kakizaki P, Chartuni JCN, Valente NYS. Sycosiform tinea barbae caused by Trichophyton rubrum and its association with autoinoculation. An Bras Dermatol. 2017;92(1):160–1.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Hay RJ. Tinea capitis: current status. Mycopathologia. 2017;182(1–2):87–93.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Pinheiro AMC, Lobato LA, Varella TCN. Dermoscopy findings in tinea. An Bras Dermatol. 2012;87(2):313–4.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Cowper SE, Knopp EA. The histopathology of primary cicatricial alopecia. Semin Cutan Med Surg. 2006;25(1):41–50.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Jaspers GJ, Werrij BG, Jagtman BA, et al. Severe kerion celsi due to Trichophyton mentogrophytes: a case report. Acta Paediatr. 2011;100(10):e181–3.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Chapalain V, Winter H, Langbein L, Le Roy JM, Labreze C, et al. Is the loose anagen hair syndrome a keratin disorder? A clinical and molecular study. Arch Dermatol. 2002;138(4):501–6.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Swink SM, Castelo-Soccio L. Loose anagen syndrome: a retrospective chart review of 37 cases. Pediatr Dermatol. 2016;33(5):507–10.PubMedCrossRefGoogle Scholar
  75. 75.
    Cantatore-Francis JL, Orlow SJ. Practical guidelines for evaluation of loose anagen hair syndrome. Arch Dermatol. 2009;145(10):1123–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Zarbo A, Shwayder I. Loose anagen hair syndrome. J Pediatr. 2018;199:282. e1.  https://doi.org/10.1016/j.jpeds.2018.03.005.CrossRefPubMedGoogle Scholar
  77. 77.
    Mirmirani P, Uno H, Price VH. Abnormal inner root sheath of the hair follicle in the loose anagen hair syndrome: an ultrastructural study. J Am Acad Dermatol. 2011;64(1):129–34.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of DermatologyHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, University of São PauloSão PauloBrazil
  2. 2.Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations